Approval · Notice of Compliance 23474 · 2020
DESFLURANE: Notice of Compliance 23474
Issued April 17, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23474
- Date
- April 17, 2020
- Company
- Blue-Zone Technologies Ltd.Concord, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- SUPRANE (Baxter Corporation)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DESFLURANE | 02498146 | Approved |
Medicinal ingredients
- DESFLURANE 100 PER